Antimicrobial use and methicillin-resistant Staphylococcus aureus in a large nursing home

Journal of the American Medical Directors Association

Volumn 5, Issue 4, 2004, Pages 256-258

  Drinka, Paul J ^a   Gauerke, Cathy ^a   Le, Debbie ^a  

^a Wisconsin Department of Veterans Affairs   (United States)

Author keywords

Antibiotic use; MRSA; Quinolone

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFTRIAXONE; CEPHALOSPORIN; COTRIMOXAZOLE; DICLOXACILLIN; ERYTHROMYCIN; METICILLIN; METRONIDAZOLE; NAFCILLIN; NITROFURANTOIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL OVERGROWTH; BACTERIUM ISOLATE; CONTROLLED STUDY; DATA ANALYSIS; DRUG USE; FEMALE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NURSING HOME; ANTIBIOTIC RESISTANCE; DRUG EFFECT; ISOLATION AND PURIFICATION; LONG TERM CARE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOGENICITY; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNITED STATES;

AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; LONG-TERM CARE; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; NURSING HOMES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WISCONSIN;

EID: 4143089412     PISSN: 15258610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-8610(04)70132-2     Document Type: Article

References (15)

1. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, Gram-negative bacilli, Clostridium difficile, and candida. Ann Intern Med 2002;136:834-844.
2. Rezende NA, Blumberg HM, Metzger BS, et al. Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission. Am J Med Sci 2002;323:117-123.
3. Muller AA, Mauny F, Bertin M, et al. Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital. Clin Infect Dis 2003;36:971-978.
4. Venezia RA, Damaracki BE, Evans AM, et al. Fluoroquinolones enhance the expression of high level oxacillin resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2000;21:124.
5. Campillo B, Dupeyron C, Richardet JP. Epidemiology of hospital-acquired infections in cirrhotic patients: Effect of carriage of MRSA and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 2001;127:443-450.
6. Blumberg HM, Rimland D, Carroll DJ, et al. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis 1991;163:1279-1285.
7. Manhold C, von Rolbicki U, Brase R, et al. Outbreaks of Staphylococcus aureus infections during treatment of late onset pneumonia with ciprofloxacin in a prospective, randomized study. Intensive Care Med 1998; 24:1327-1330.
8. Drinka P, Faulks JT, Gauerke C, et al. A comparison of previous antibiotic therapy following isolation of MRSA versus MSSA in nursing home residents: A preliminary investigation. J Am Med Dir Assoc 2002;3:356-359.
9. Bisognano C, Vaudaux P, Rohner P, et al. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 2000;44:1428-1437.
10. Crowcroft NS, Ronveaux O, Monnet DL, et al. Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian Hospitals. Infect Control Hosp Epidemiol 1999;20:31-36.
11. Weber SG, Gold HS, Karchmer AW, et al. Exposure to quinolones is a risk factor for methicillin-resistant (MRSA), but not for methicillin-susceptible Staphylococcus aureus (MSSA). ICAAC 42nd Annual Scientific Meeting, 2002; Abstract K-105, p 305.
12. Dziekan G, Hahn A, Thune K, et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: Investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 2000;46:263-270.
13. Hori S, Sunley R, Tami A, et al. The Nottingham Staphylococcus aureus population study: Prevalence of MRSA among the elderly in a university hospital. J Hosp Infect 2002;50:25-29.
14. Monnet DL. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: Possible implications for control. Infect Control Hosp Epidemiol 1998;19:552-559.
15. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002;49:999-1005.